| Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975) |
|---|
| 06/20/2007 | CN1982321A Production of flax lignan |
| 06/20/2007 | CN1322001C Novel compounds that inhibit factor Xa activity |
| 06/19/2007 | US7232900 making a glycosyl halide comprising reacting an O-silyl glycoside with an alpha , alpha -dihalomethyl alkyl ether in the presence of zinc chloride, zinc bromide or boron trifluoride; intermediate to synthesis of the immunostimulants |
| 06/19/2007 | US7232805 Cobalamin conjugates for anti-tumor therapy |
| 06/14/2007 | WO2007066805A1 Lincomycin derivative and antibacterial agent containing the same as active ingredient |
| 06/14/2007 | WO2006052886A8 Metabolites of certain [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof |
| 06/14/2007 | US20070135624 Method for preparing 4-demethyldaunorubicin |
| 06/14/2007 | US20070135444 Treatment of neuroblastoma |
| 06/14/2007 | US20070135378 Method for the direct synthesis of oligorhamnosides, composition comprising oligorhamnosides and use thereof as a medicament |
| 06/14/2007 | US20070135358 Steroid modified solatrioses |
| 06/14/2007 | US20070135357 Anti-hypercholesterolemic compounds |
| 06/14/2007 | US20070134729 Novel antibacterial agents |
| 06/14/2007 | US20070134187 Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders |
| 06/14/2007 | DE102005058542A1 Erythruloseester als UV Filter Erythruloseester as UV filters |
| 06/13/2007 | EP0988060B1 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy |
| 06/13/2007 | CN1980944A Process for preparing a pulverulent alditol acetal composition |
| 06/13/2007 | CN1977837A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 06/13/2007 | CN1977836A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 06/12/2007 | US7230030 Ether, alcohol, ester, carbamate or carbonate,sulfamate or silanol substituted-3,3-diphenylpropylamine derivatives; prodrugs of antimuscarinic agents with superior pharmacokinetic properties |
| 06/07/2007 | WO2007064954A2 Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents |
| 06/07/2007 | WO2007028812A3 Selected cgrp antagonists method for production and use thereof as medicament |
| 06/07/2007 | WO2007021900A3 Compositions and methods for treating wounds |
| 06/07/2007 | US20070129315 3-O- beta -D-xylopyranosyl-3-O-demethylthiocolchicine or 3-O- beta -L-xylopyranosyl-3-O-demethylthiocolchicine; gout , antiinflammation; muscle relaxant |
| 06/07/2007 | CA2632968A1 Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents |
| 06/06/2007 | EP1499743B1 Means and methods for detecting endoglycosidase activity |
| 06/06/2007 | CN1974589A Process of extracting rhanolipid as biosurfactant |
| 06/06/2007 | CN1319981C Preparation process of plantago fotal glycocide and its application in medicine |
| 06/05/2007 | US7226758 glial derived neurotrophic factor (GDNF) isolated from serum-free growth conditioned medium of glioblastoma cells; for preventing and treating nerve damage and nerve related diseases such as Parkinson's disease; genetic engineering |
| 06/01/2007 | CA2568472A1 Polymeric compositions for controlled release or delivery of pharmacologically active agents |
| 05/31/2007 | US20070122535 Process for preparing solidified maltitol and its use in food and pharma products |
| 05/30/2007 | EP1789429A2 Bifunctional antibiotics for targeting rrna and resistance causing enzymes and for inhibition of anthrax lethal factor |
| 05/30/2007 | EP1789428A1 Monosaccharide derivatives |
| 05/30/2007 | CN1972955A Radiosensitizer |
| 05/30/2007 | CN1318439C Preparation method of amygdalin and its application in preparation of amygdalin preparation for promoting the blood circulation of heart, brain, pancreas and wound |
| 05/29/2007 | US7223770 Tocopherol-modified therapeutic drug compounds |
| 05/29/2007 | US7223738 Inhibitors of Akt activity |
| 05/29/2007 | CA2168080C Process for the preparation of 1-(2'-deoxy-2',2'-difluoro- d-ribopentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro- beta-d-ribo-pentopyranose |
| 05/24/2007 | WO2006029221B1 Anti-tumor compounds with angeloyl groups |
| 05/24/2007 | US20070116665 Novel derivatives of morphine-6-glucuronide, pharmaceutical compositions containing them, their preparation method and their uses |
| 05/23/2007 | EP1787993A1 Crystalline maltitol powder less prone to consolidation and method for production thereof |
| 05/23/2007 | CN1966513A Process for preparing modified fatty alcohol polyethenoxy ether |
| 05/23/2007 | CN1317288C Method for producing tablet, baked product or chewing gum |
| 05/22/2007 | US7220727 Aminoglycosides as antibiotics |
| 05/22/2007 | CA2276694C New fatty acid derivatives |
| 05/22/2007 | CA2206296C Low rigidity liposomal antibacterial composition |
| 05/17/2007 | US20070111951 Novel galactosylceramide analogues, and beta-glucocerebrosidase activator, external skin preparations and method of activating beta-glucocerebrosidase using the same |
| 05/16/2007 | EP1785430A1 Rapamycin carbohydrate derivatives |
| 05/16/2007 | EP1784413A1 Alkoxylated sucrose esters composition |
| 05/16/2007 | EP1784412A1 Improved synhesis of alkoxylated sucrose esters |
| 05/16/2007 | CN1962592A Method for separating and purifying polydatin and resveratrol from traditional Chinese medicine giant knotweed |
| 05/16/2007 | CN1315860C Process for extracting lincomycin |
| 05/16/2007 | CN1315859C Lincomycin derivatives possessing antibacterial activity |
| 05/15/2007 | US7217697 Sodium dependent glucose transporter 1 inhibitors; blocking small intestine absorption of glucose; diabetes |
| 05/15/2007 | US7217696 Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof |
| 05/15/2007 | US7217335 Method of manufacturing a soft hearing aid |
| 05/10/2007 | WO2007009637A3 Complexes containing perfluoroalkyl, their use as contrast media for nmr, x-ray and radio diagnosis and radiotherapy |
| 05/09/2007 | EP1783221A1 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 05/09/2007 | EP1783137A1 Galactose derivative, drug carrier and medicinal composition |
| 05/09/2007 | EP1783122A1 Process for production of azulene derivatives and intermediates for the synthesis of the same |
| 05/09/2007 | EP1783110A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 05/09/2007 | CN1314695C Method for preparing alkyl glucoside |
| 05/08/2007 | US7214794 Capable of crossing cell membrane; induction apoptosis in human cancer cells |
| 05/08/2007 | CA2339528C Hexahydropyrazolo[4,3-c]pyridine metabolites |
| 05/08/2007 | CA2247526C Maltitol crystals having specific shapes, crystalline compositions containing them and processes for preparing them |
| 05/08/2007 | CA2215605C Osmotically controlled fermentation process for the preparation of acarbose |
| 05/03/2007 | WO2007050668A1 Analogs of alpha galactosylceramide and uses thereof |
| 05/03/2007 | WO2007049819A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient |
| 05/03/2007 | US20070099848 Rapamycin carbohydrate derivatives |
| 05/03/2007 | CA2627640A1 Therapeutic drug for suppressing functions of nkt cells containing glycolipid derivative as active ingredient |
| 05/03/2007 | CA2626997A1 Analogs of alpha galactosylceramide and uses thereof |
| 05/02/2007 | EP1778709A2 Polysulfated glycosides and salts thereof |
| 05/02/2007 | EP1778212A2 Ketogenic saccharides |
| 05/02/2007 | CN1956992A Anthracycline derivatives |
| 05/02/2007 | CN1313475C Use of polygonum cuspidatum tannic acid of polygonum cuspidatum extract in the preparation of medicine for lowering blood sugar and treating diabetes |
| 05/01/2007 | US7211663 Antiinflammatory agents; immobilized on solid support |
| 04/26/2007 | WO2007045469A1 Hexosylceramides as adjuvants and their uses in pharmaceutical compositions |
| 04/26/2007 | WO2006067173A3 Antithrombotic dual inhibitors comprising a biotin residue |
| 04/26/2007 | CA2624617A1 Hexosylceramides as adjuvants and their uses in pharmaceutical compositions |
| 04/25/2007 | EP1777236A1 Modified saccharides having improved stability in water |
| 04/25/2007 | EP1776963A1 Hexosylceramides as adjuvants and their uses in pharmaceutical compositions |
| 04/25/2007 | EP1776375A2 Certain aminoalkyl glucosaminide phosphate compounds and their use |
| 04/25/2007 | CN1953987A Method for construction and use of kluyveromyces lactis promoter variants in k. lactis that substantially lack e. coli transcriptional capability |
| 04/25/2007 | CN1951950A Helicid modifier and its preparation method and uses |
| 04/25/2007 | CN1951896A Benzobinaphthoquinone derivative with anticancer activity |
| 04/25/2007 | CN1312165C Aryl 5-thio-beta-D-glucopyranoside derivatives and remedies for diabetes containing the same |
| 04/24/2007 | CA2203155C Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer |
| 04/19/2007 | WO2007042469A2 Anticoagulant antithrombotic dual inhibitors comprising a biotin label |
| 04/19/2007 | US20070087981 Water Soluble and Palatable Complexes |
| 04/19/2007 | CA2624867A1 Antithrombotic compound |
| 04/19/2007 | CA2624588A1 Anticoagulant antithrombotic dual inhibitors comprising a biotin label |
| 04/18/2007 | EP1773855A1 Novel compounds that inhibit factor xa activity |
| 04/18/2007 | CN1950093A Oral flora-improving agent, antibacterial agent and growth promoter |
| 04/18/2007 | CN1948326A Method of preparing trichloro sucrose-6-organic acid ester |
| 04/18/2007 | CN1948248A Wheat bran total alkyl phenol extract and its preparation method and application |
| 04/18/2007 | CN1947738A Novel pharmaceutical use of total sennoside in senna, and method for preparing the same |
| 04/17/2007 | US7205001 Anticancer agents; using potassium arsenite therapy and radiation |
| 04/12/2007 | WO2007041514A2 Process for selectively extracting procyanidins |
| 04/12/2007 | WO2007038829A1 Method of drug design |
| 04/12/2007 | WO2006029221A3 Anti-tumor compounds with angeloyl groups |
| 04/12/2007 | CA2619457A1 Method of drug design |